NEW YORK (GenomeWeb News) - Bioinformatics company GeneGo today said Chang Gung University in Taiwan has upgraded its web license for the company’s MetaCore platform to a permanent installation and has licensed the company’s MapEditor, which is used to draft and edit pathways maps.
 
The MetaCore 4.1 computation platform is used in the target selection, validation, and identification of biomarkers for disease and drug development.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.